Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Biokinetics and Dosimetry of 177Lu-Pentixather

Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm and Andreas K. Buck
Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: https://doi.org/10.2967/jnumed.121.262295
Heribert Hänscheid
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Schirbel
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Hartrampf
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina Kraus
2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudolf A. Werner
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hermann Einsele
2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Jürgen Wester
3Department of Pharmaceutical Radiochemistry, TU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Lassmann
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Kortüm
2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas K. Buck
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 5 754-760
DOI 
https://doi.org/10.2967/jnumed.121.262295
PubMed 
34413147

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication March 15, 2021
  • Revision received August 5, 2021
  • Published online April 28, 2022.

Article Versions

  • previous version (August 19, 2021 - 09:49).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Heribert Hänscheid1,
  2. Andreas Schirbel1,
  3. Philipp Hartrampf1,
  4. Sabrina Kraus2,
  5. Rudolf A. Werner1,
  6. Hermann Einsele2,
  7. Hans-Jürgen Wester3,
  8. Michael Lassmann1,
  9. Martin Kortüm2 and
  10. Andreas K. Buck1
  1. 1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
  2. 2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
  3. 3Department of Pharmaceutical Radiochemistry, TU Munich, Munich, Germany
  1. For correspondence or reprints, contact Heribert Hänscheid (haenscheid_h{at}ukw.de).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 10 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • CXCR4-targeted theranostics in oncology
    Andreas K. Buck, Sebastian E. Serfling, Thomas Lindner, Heribert Hänscheid, Andreas Schirbel, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 12
  • C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
    Andreas K. Buck, Götz Ulrich Grigoleit, Sabrina Kraus, Andreas Schirbel, Michael Heinsch, Niklas Dreher, Takahiro Higuchi, Constantin Lapa, Heribert Hänscheid, Samuel Samnick, Hermann Einsele, Sebastian E. Serfling, Rudolf A. Werner
    Journal of Nuclear Medicine 2023 64 1
  • Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine
    Circe D. van der Heide, Simone U. Dalm
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 13
  • 68Ga-Labeled Cystine Knot Peptide Targeting Integrin αvβ6 for Lung Cancer PET Imaging
    Jingyun Ren, Shiyu Zhu, Guojin Zhang, Xiaoyue Tan, Ling Qiu, Jianguo Lin, Lei Jiang
    Molecular Pharmaceutics 2022 19 7
  • CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors
    Ingo Hartlapp, Philipp E. Hartrampf, Sebastian E. Serfling, Vanessa Wild, Alexander Weich, Leo Rasche, Sabine Roth, Andreas Rosenwald, Patrick W. Mihatsch, Anne Hendricks, Armin Wiegering, Verena Wiegering, Heribert Hänscheid, Andreas Schirbel, Rudolf A. Werner, Andreas K. Buck, Hans-Jürgen Wester, Hermann Einsele, Volker Kunzmann, Constantin Lapa, K. Martin Kortüm
    Journal of Nuclear Medicine 2023 64 9
  • Detecting CXCR4 Expression in Meningioma on68Ga-Pentixafor PET/MRI
    Simone Krebs, Jazmin Schwartz, Christian Grommes, Robert J. Young, Heiko Schöder, Marius E. Mayerhoefer
    Journal of Nuclear Medicine 2023 64 4
  • Radiopharmaceutical Therapy
    Andreas K. Buck, Heribert Hänscheid, Sebastian E. Serfling, Takahiro Higuchi, Leo Rasche, Hermann Einsele, Rudolf A. Werner
    2023
  • Theranostics in Hematooncology
    Andreas K. Buck, Sebastian E. Serfling, Sabrina Kraus, Samuel Samnick, Niklas Dreher, Takahiro Higuchi, Leo Rasche, Hermann Einsele, Rudolf A. Werner
    Journal of Nuclear Medicine 2023 64 7
  • Theranostika in der Nuklearmedizin
    Ann-Christin Eder, Matthias Eder
    Wiener klinisches Magazin 2022 25 5-6
  • Theranostika in der Nuklearmedizin
    Ann-Christin Eder, Matthias Eder
    Der Onkologe 2022 28 2

Article usage

Article usage: August 2021 to November 2023

AbstractFullPdf
Aug 2021519033
Sep 2021358022
Oct 2021731028
Nov 2021259029
Dec 2021255024
Jan 2022192021
Feb 2022199027
Mar 2022138091
Apr 20221926181
May 2022401417133
Jun 202224522463
Jul 20224952339
Aug 20222681819
Sep 2022466636
Oct 20223262941
Nov 20224710229
Dec 20224139632
Jan 20234540141
Feb 20231636741
Mar 20232138751
Apr 20231830029
May 20231615729
Jun 20231821341
Jul 20233128438
Aug 20232733633
Sep 20232429238
Oct 20232412938
Nov 20232116628
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (5)
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biokinetics and Dosimetry of 177Lu-Pentixather
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Biokinetics and Dosimetry of 177Lu-Pentixather
Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm, Andreas K. Buck
Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: 10.2967/jnumed.121.262295

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biokinetics and Dosimetry of 177Lu-Pentixather
Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm, Andreas K. Buck
Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: 10.2967/jnumed.121.262295
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • An Intrapatient Dosimetry Comparison of 177Lu-rhPSMA-10.1 and 177Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
  • 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study
  • Clinical Characterization of [18F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modeling, Variability, and Soticlestat Occupancy
Show more Clinical Investigation

Similar Articles

Keywords

  • pentixather
  • biokinetics
  • dosimetry
  • CXCR4
  • endoradiotherapy
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire